Literature DB >> 29588843

Protracted severe systemic cytomegalovirus disease in an immunosuppressed patient with ulcerative colitis.

Matthew James Armstrong1, Tom Thomas2, Tariq Iqbal3, Ralph Boulton3, Jason Goh3.   

Abstract

A 33-year-old man with ulcerative colitis presented with 5-day history of fever, night sweats, abdominal pain and increased stool frequency. He was on mesalazine M/R 1 g once daily, 6-mercaptopurine (6-MP) 75 mg once daily and prednisolone 40 mg once daily. Examination revealed fever and tachycardia. Blood examinations identified a persistent leucopenia, C reactive protein of 23 mg/L and an initial alanine transaminase of 855 IU/L. Flexible sigmoidoscopy revealed well-demarcated, punched-out ulcers in the proximal rectum and distal sigmoid, with histology pathognomonic of cytomegalovirus (CMV). CMV DNA PCR was 51 140 copies/mL. Despite prompt withdrawal of 6-MP, steroids and initiation of intravenous ganciclovir on day 2 of admission, his systemic illness, diarrhoea and fever persisted until day 19 of antiviral therapy. Other copathogens and lymphoma were ruled out on serology and CT scan, respectively. After an unusually prolonged course of antiviral therapy, the patient made a full clinical recovery, bloods normalised and there were two consecutive undetectable CMV DNA PCRs.

Entities:  

Keywords:  ibd clinical; immunodeficiency; infectious diarrhoea; ulcerative colitis

Year:  2017        PMID: 29588843      PMCID: PMC5868449          DOI: 10.1136/flgastro-2017-100889

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  9 in total

1.  Cytomegalic inclusion disease and ulcerative colitis; report of a case in a young adult.

Authors:  R D POWELL; N E WARNER; R S LEVINE; J B KIRSNER
Journal:  Am J Med       Date:  1961-02       Impact factor: 4.965

2.  International consensus guidelines on the management of cytomegalovirus in solid organ transplantation.

Authors:  Camille N Kotton; Deepali Kumar; Angela M Caliendo; Anders Asberg; Sunwen Chou; David R Snydman; Upton Allen; Atul Humar
Journal:  Transplantation       Date:  2010-04-15       Impact factor: 4.939

Review 3.  Review article: cytomegalovirus and inflammatory bowel disease.

Authors:  K Sager; S Alam; A Bond; L Chinnappan; C S Probert
Journal:  Aliment Pharmacol Ther       Date:  2015-02-16       Impact factor: 8.171

4.  Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Authors:  J F Rahier; F Magro; C Abreu; A Armuzzi; S Ben-Horin; Y Chowers; M Cottone; L de Ridder; G Doherty; R Ehehalt; M Esteve; K Katsanos; C W Lees; E Macmahon; T Moreels; W Reinisch; H Tilg; L Tremblay; G Veereman-Wauters; N Viget; Y Yazdanpanah; R Eliakim; J F Colombel
Journal:  J Crohns Colitis       Date:  2014-03-06       Impact factor: 9.071

5.  Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience.

Authors:  Jonas Bontà; Jonas Zeitz; Pascal Frei; Luc Biedermann; Michael C Sulz; Stephan R Vavricka; Sylvie Scharl; Michael Fried; Gerhard Rogler; Michael Scharl
Journal:  Eur J Gastroenterol Hepatol       Date:  2016-11       Impact factor: 2.566

6.  Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

Authors:  Katsuyoshi Matsuoka; Yasushi Iwao; Takeshi Mori; Atsushi Sakuraba; Tomoharu Yajima; Tadakazu Hisamatsu; Susumu Okamoto; Yuichi Morohoshi; Motoko Izumiya; Hitoshi Ichikawa; Toshiro Sato; Nagamu Inoue; Haruhiko Ogata; Toshifumi Hibi
Journal:  Am J Gastroenterol       Date:  2006-12-11       Impact factor: 10.864

Review 7.  Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis.

Authors:  Tushar Shukla; Siddharth Singh; Edward V Loftus; David H Bruining; Jeffrey D McCurdy
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

8.  A model for identifying cytomegalovirus in patients with inflammatory bowel disease.

Authors:  Jeffrey D McCurdy; Andrea Jones; Felicity T Enders; Jill M Killian; Edward V Loftus; Thomas C Smyrk; David H Bruining
Journal:  Clin Gastroenterol Hepatol       Date:  2014-06-30       Impact factor: 11.382

9.  Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study.

Authors:  Neeraja Kambham; Rohini Vij; Christine A Cartwright; Teri Longacre
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.